SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-052554
Filing Date
2018-09-28
Accepted
2018-09-28 16:21:42
Documents
2
Period of Report
2018-09-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1534
2 POA DOCUMENT poa.txt EX-24.3_811100 3958
  Complete submission text file 0001209191-18-052554.txt   6849
Mailing Address 2525 DUPONT DR IRVINE CA 92612
Business Address
EDWARDS JEFFREY L (Reporting) CIK: 0001190642 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37783 | Film No.: 181094427

Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Issuer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: GA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations